If you didn’t find what you were looking for, try a new search!

Instructions to the Authors

  About the Journal |  Scope of the journal|  The Editorial Process |  Clinical trial registry | Authorship Criteria |  Contribution Details |   Conflicts of Interest/ …

Combination phenylbutyrate/gemcitabine therapy effectively inhibits in vitro and in vivo growth of NSCLC by intrinsic apoptotic pathways

Bodo Schniewind1, Kirsten Heintz2, Roland Kurdow1, Ole Ammerpohl2, Anna Trauzold2, Doris Emme2, Peter Dohrmann1, Holger Kalthoff21 Hospital for General and Thoracic Surgery, Schleswig-Holstein University Hospitals, Campus Kiel, Arnold-Heller-Str …